Novavax launches Phase 3 COVID vaccine trials with plans to enroll 30,000 volunteers in the US and Mexico
Fact check: No evidence SARS-CoV-2 is an HIV-based bioweapon; trials show that vaccines against the virus are effective
Fact check: No evidence SARS-CoV-2 is an HIV-based bioweapon; trials show that vaccines against the virus are effective
